Tag Archives: patents

Last Chapter In The “Corn Wars” Or Just The Latest?

Posted on February 29, 2012 by Warren Woessner

On February 28, 2012, a three-judge panel of the Fed. Cir. ruled that the Board properly ruled that Monsanto prevailed in interference no. 105,728, involving the patent claims directed broadly to transgenic corn. (A copy of this ruling is found at … Continue reading →

Posted in Ag Biotechnology, Interferences | Tagged , , , , , , , , , , , | 1 Comment

Bayer v. Lupin – Patenting The Label Redux

Posted on February 28, 2012 by Warren Woessner

In my post of January 13, 2011, I discussed AstraZeneca LP v. Apotex, a Fed. Cir. decision in which AZ argued successfully that the proposed  Apotex labeling for an anti-asthma drug would induce infringement if the generic were marketed with … Continue reading →

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , | Leave a comment

Supreme Court Declines To Review “New And Improved” Written Description Requirement

Posted on February 22, 2012 by Warren Woessner

On Tuesday, the Supreme Court denied Centocor’s (now “Janssen”) petition for cert. and so let stand a ruling that Centocor’s patents on humanized monoclonal antibodies (covering Abbott’s Humira) are invalid for failure to meet the written description requirement (WDR) of … Continue reading →

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , , , , | Leave a comment

Griffith Hack And Ambercite Map The Alzheimer’s Disease Patent Landscape

Posted on February 17, 2012 by Warren Woessner

Although I received this report: “Clearing The Fog; Patenting Trends For The Treatment Of Alzheimer’s Disease” both directly and from a number of colleagues, I won’t presume that it has been widely read, but it should be. (A copy of the … Continue reading →

Posted in Miscellaneous | Tagged , , , , , | Leave a comment